Literature DB >> 34255103

[Oncologic aspects in treatment of pathologic fractures].

H Eggers1,2, J Wichmann2,3, M Omar4, F Länger2,5, P Ivanyi6,7,8.   

Abstract

BACKGROUND: Pathological fractures are not only incisive events for tumor patients often with the need of surgical treatment but also often represent a relevant challenge in the overall concept of oncological treatment.
OBJECTIVE: The aim of this article is to illustrate the necessity of a pre-interventional interdisciplinary consideration of disease-specific and patient-specific characteristics.
MATERIAL AND METHODS: A literature search and evaluation of existing guidelines were carried out including the keywords "bone metastases" and "pathological fractures" with respect to the oncological and radiotherapeutic treatment.
RESULTS: An essential classification of the surgical and other needs for treatment is carried out by the identification of the underlying disease and dissemination situation. For tumor-related pathological fractures a palliative treatment situation is present in most cases. Nevertheless, a possible oligometastasis and an increasing number of effective systemic treatment methods must be taken into consideration when planning the surgical treatment. In addition to the therapeutic emergency indications in spinal compression or symptomatic hypercalcemia, both additive radiotherapy and supplementary pharmaceutical osteoprotection have to be addressed in this context. Radiotherapy in particular represents an effective alternative option for symptom and tumor control.
CONCLUSION: The work-up of the multifaceted oncological treatment concept represents an interdisciplinary challenge, which ideally defines the further treatment procedure, including fracture treatment, in an interdisciplinary tumor board within an overall oncological concept.
© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Bone neoplasms; Combined modality treatment; Hypercalcemia; Palliative care; Radiotherapy

Mesh:

Year:  2021        PMID: 34255103     DOI: 10.1007/s00113-021-01051-1

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  1 in total

Review 1.  Bisphosphonates and other bone agents for breast cancer.

Authors:  Brent O'Carrigan; Matthew Hf Wong; Melina L Willson; Martin R Stockler; Nick Pavlakis; Annabel Goodwin
Journal:  Cochrane Database Syst Rev       Date:  2017-10-30
  1 in total
  1 in total

Review 1.  [Update on 3D printing in the surgery of musculoskeletal tumors].

Authors:  Mohamed Omar; Martin Schulze; Nico Bruns; Daniel Kotrych; Georg Gosheger; Max Ettinger
Journal:  Unfallchirurg       Date:  2022-03-21       Impact factor: 1.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.